Sanolla provides physicians and patients with smart diagnostic solutions designed to support the early assessment and monitoring of cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, COVID-19, and more. Based on AI-powered detection and analysis of previously inaccessible body infrasounds and other important vital signs (e.g., ECG, heart rate, oxygen level, body temperature, and respiratory cycle), Sanolla's products can provide immediate and accurate assessment, reducing unnecessary in-clinic visits, saving time and money, and lowering the associated risk of exposure to infections.